Skip to main content

and
  1. Article

    Open Access

    Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses

    Olfactory neuroblastoma is a rare malignancy of the anterior skull base typically treated with surgery and adjuvant radiation. Although outcomes are fair for low-grade disease, patients with high-grade, recurr...

    Riley M. Larkin, Diana C. Lopez, Yvette L. Robbins in Journal of Translational Medicine (2024)

  2. No Access

    Article

    Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach?

    Substantial interest exists in the effects of immunotherapy; however, radiation therapy also has the potential to stimulate an antitumour immune response. In this Perspectives, the authors describe the rationa...

    Michael B. Bernstein, Sunil Krishnan, James W. Hodge in Nature Reviews Clinical Oncology (2016)

  3. Article

    Open Access

    Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine

    Growing awareness of the complexity of carcinogenesis has made multimodal therapies for cancer increasingly compelling and relevant. In recent years, immunotherapy has gained acceptance as an active therapeuti...

    Anna R Kwilas, Andressa Ardiani, Renee N Donahue in Journal of Translational Medicine (2014)